导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.23% | 4149/4773 |
| 近一周 | -2.70% | 2877/5462 |
| 近一月 | -3.50% | 1792/5421 |
| 近一季 | -0.39% | 824/5209 |
| 近半年 | -13.06% | 3820/4920 |
| 近一年 | -22.08% | 3968/4366 |
| 近两年 | -4.13% | 2930/2954 |
| 近三年 | -27.65% | 2193/2253 |
| 成立以来 | 56.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.15% 4050/4961 |
-15.06% 4635/5312 |
- - |
- - |
| 2025 | -3.07% 3349/4813 |
1.83% 1540/3635 |
-5.15% 3539/4076 |
5.62% 3574/4524 |
-4.98% 3504/4813 |
| 2024 | -3.37% 2215/3463 |
0.94% 919/2808 |
-8.43% 2236/3014 |
14.83% 1900/3129 |
-8.95% 2891/3463 |
| 2023 | -16.78% 1698/2656 |
1.81% 1509/2280 |
-11.89% 2170/2385 |
-0.76% 445/2515 |
-6.51% 1805/2655 |
| 2022 | -11.19% 231/2207 |
-17.65% 1235/1919 |
23.29% 16/2016 |
-11.90% 606/2113 |
-0.72% 1642/2208 |
| 2021 | 1.68% 658/1822 |
-3.03% 746/1255 |
7.94% 659/1330 |
-6.89% 1005/1466 |
4.34% 340/1822 |
| 2020 | 68.72% 82/1250 |
-2.42% 261/1028 |
23.68% 188/1067 |
15.62% 205/1164 |
20.91% 60/1184 |
| 2019 | - - |
- - |
5.97% 14/804 |
5.09% 166/850 |
4.31% 811/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 前海开源MSCI中国A股消费C VS. 长安沪深300非周期A(740101) |